Warning: VALN is at high risk of performing badly

Valneva SE (NASDAQ:VALN) has characteristics which have been historically associated with poor future stock performance. VALN has inferior profitability and decelerating momentum when compared to other Health Care stocks, to the point that it gets a Sell rating from our Quant rating system. Stocks rated Sell or worse by our Quant rating system have massively underperformed the S&P 500, as this article will describe.
The company has Cash From Operations (TTM) of $-218.07M while the Health Care sector median is $-14.1M.

The company has 1Y Price Performance of -51.23% while the Health Care sector median is 7.64%.

Due to these factors our quant model has rated Valneva SE as Sell and the company has an overall rank of 879 out of 2954 in the Health Care sector. Compared to the S&P 500, stocks rated Sell or worse were down 20% on average per year over the last 10 years.

If you are looking for alternatives to Valneva SE (NASDAQ:VALN) see our top rated Health Care sector stocks by quant rating. Our top rated stocks have beaten the S&P 500 by 1300% over the last 10 years.
The Sell warnings are based on our Quant Ratings, a systematic quantitative model which generates Seeking Alpha’s Sell ratings. For information about Quant Ratings, backtesting and its limitations, please read more here.

Tags: VALN